98 results on '"Pirisi A."'
Search Results
2. Effectiveness and safety of glecaprevir/pibrentasvir in chronic hepatitis C patients: Results of the Italian cohort of a post-marketing observational study
3. HepaDisk – A new quality of life questionnaire for HCV patients
4. Identification of mutations in circulating cell-free tumour DNA as a biomarker in hepatocellular carcinoma
5. Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study
6. Transcatheter aortic valves produce unphysiological flows which may contribute to thromboembolic events: An in-vitro study
7. Relation among anti-rheumatic drug therapy, CD14+CD16+ blood monocytes and disease activity markers (DAS28 and US7 scores) in rheumatoid arthritis: A pilot study
8. Evaluation of the red cell distribution width as a biomarker of early mortality in hepatocellular carcinoma
9. Differences in the peptide profile of raw and pasteurised ovine milk cheese and implications for its bioactive potential
10. Role of beta-blockers in patients with COPD: current perspective
11. Pegylated interferon α plus ribavirin for the treatment of chronic hepatitis C: A multicentre independent study supported by the Italian Drug Agency
12. Methodological assessment of HCC literature
13. 969P Lenvatinib versus sorafenib as a second-line option in patients with unresectable hepatocellular carcinoma previously treated with atezolizumab plus bevacizumab: An observational study
14. Hepatitis B virus and lymphomagenesis: Novel insights into an occult relationship
15. Association between the epidermal growth factor rs4444903 G/G genotype and advanced fibrosis at a young age in chronic hepatitis C
16. Liquid biopsy for hepatocellular carcinoma: Preliminary results on the association between postoperative early recurrence and the expression pattern of circulating tumor cells
17. Gelation properties of casein micelles during combined renneting and bacterial fermentation: Effect of concentration by ultrafiltration
18. A multi-center comparative study of Atezolizumab plus Bevacivumab and Lenvatinib as primary systemic therapy for unresectable hepatocellular carcinoma (HCC): focus on thrombotic and hemorrhagic adverse events
19. Spleen stiffness measurement improves non-invasive prediction of clinically significant portal hypertension in primary biliary cholangitis
20. Burden of Hepatitis D Virus infection in Italy: interim results from a prospective multicentre nationwide study
21. Identification of factors associated with primary refractoriness to atezolizumab plus bevacizumab in patients with advanced hepatocellular carcinoma
22. TGF-β1 genotypes in cirrhosis: Relationship with the occurrence of liver cancer
23. Relationship between the enzymatic composition of lamb rennet paste and proteolytic, lipolytic pattern and texture of PDO Fiore Sardo ovine cheese
24. Unsuspected strongyloidiasis in hospitalised elderly patients with and without eosinophilia
25. Quantitative treatment of the hyponatremia of cirrhosis
26. Hyponatremia in liver cirrhosis: pathophysiological principles of management
27. The influence of the enzymatic composition of lamb rennet paste on some properties of experimentally produced PDO Fiore Sardo cheese
28. Effect of the use of three different lamb paste rennets on lipolysis of the PDO Pecorino Romano Cheese
29. Genetic differentiation of two distinct chemotypes of Ferula communis ( Apiaceae) in Sardinia (Italy)
30. Clinical features of patients with new onset of autoimmune hepatitis following SARS-CoV-2 vaccination
31. Circulating Tumor Cells in Hepatocellular Carcinoma (HCC) and their Association with Early Recurrence after Surgery: A Preliminary Study
32. Synthesis and D2-like binding affinity of new derivatives of N-(1-ethyl-2-pyrrolidinylmethyl)-4,5-dihydro-1H-benzo[g]indole-3-carboxamide and related 4H-[1]benzothiopyrano[4,3-b]pyrrole and 5,6-dihydro-4H-benzo[6,7]cyclohepta[b]pyrrole-3-carboxamide analogues
33. Epidemiological and clinical profile of 302 patients with primary biliary cholangitis in Piedmont and Liguria
34. Early HCC Recurrence after Surgery and Circulating Tumor Cells Expression Pattern after Liquid Biopsy. A Preliminary Study
35. OC.05.4 Y90-RADIOEMBOLIZATION VERSUS SORAFENIB IN LOCALLY ADVANCED HCC WITH INTRAHEPATIC NEOPLASTIC PORTAL VEIN THROMBOSIS: THE PIEDMONT-AOSTA VALLEY ONCOLOGY NETWORK EXPERIENCE
36. Cerebral nervous system vasculitis in a Covid-19 patient with pneumonia
37. The Piedmont-Aosta Valley Oncology Network experience in locally advanced HCC with intrahepatic neoplastic portal vein thrombosis: Y90-radioembolization versus Sorafenib
38. Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study
39. Replacement of fat with long-chain inulin in a fresh cheese made from caprine milk
40. Sorafenib in clinical practice: Pooled analysis of two prospective observational studies in hepatocellular carcinoma (HCC)
41. L10 - Final results of the gideon study according to patient etiology: The italian experience
42. L11 - Hepatocellular Carcinoma In Elderly Patients: final results of The Italian Cohort Of GIDEON (Global Investigational of therapeutic DEcisions in HCC and of its treatment with sorafeNib) Study
43. P-111 Final results of the GIDEON (Global Investigational of therapeutic DEcisions in HCC and Of its treatment with sorafeNib) study according to patient etiology: The Italian experience
44. P-110 Hepatocellular carcinoma in elderly patients: Final results of the Italian cohort of GIDEON study
45. 17β-Estradiol inhibits hepatitis C (HCV) infection via binding to its receptor
46. Avi Friedman: designs on a healthy future
47. The red cell distribution width (RDW) is a novel powerful, inexpensive predictor of survival for patients who present with hepatocellular carcinoma
48. F-03 Age and gender influence the achievement of SVR in chronic hepatitis C patients carrying favourable interleukin 28-B genotypes
49. F-4 Recipient's vitamin D receptor genetic polymorphisms identify HCV positive liver transplanted patients at lower risk of graft fibrosis progression due to recurrent hepatitis C
50. F-2 Interaction between vitamin D binding protein polymorphisms and vitamin D levels in the prediction of antiviral response in chronic hepatitis C
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.